NASDAQ:PMD - Psychemedics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$14.91 -0.47 (-3.06 %)
(As of 12/18/2018 04:00 PM ET)
Previous Close$15.38
Today's Range$14.91 - $15.32
52-Week Range$14.91 - $22.88
Volume17,800 shs
Average Volume13,801 shs
Market Capitalization$87.29 million
P/E Ratio17.81
Dividend Yield4.54%
Beta0.75
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company's tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, synthetic cannabinoids, and benzodiazepines, as well as opiates, including heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine. The company offers its services to employers for applicant and employee testing; treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use; and Fortune 500 companies and small to mid-size corporations, as well as school and government entities. Psychemedics Corporation was founded in 1985 and is headquartered in Acton, Massachusetts.

Receive PMD News and Ratings via Email

Sign-up to receive the latest news and ratings for PMD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PMD
Previous Symbol
CUSIPN/A
Phone978-206-8220

Debt

Debt-to-Equity Ratio0.09
Current Ratio2.73
Quick Ratio2.73

Price-To-Earnings

Trailing P/E Ratio17.81
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$39.70 million
Price / Sales2.07
Cash Flow$1.4254 per share
Price / Cash Flow10.46
Book Value$3.39 per share
Price / Book4.40

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$6.12 million
Net Margins14.24%
Return on Equity26.58%
Return on Assets18.41%

Miscellaneous

Employees231
Outstanding Shares5,510,000
Market Cap$87.29 million
OptionableNot Optionable

Psychemedics (NASDAQ:PMD) Frequently Asked Questions

What is Psychemedics' stock symbol?

Psychemedics trades on the NASDAQ under the ticker symbol "PMD."

How often does Psychemedics pay dividends? What is the dividend yield for Psychemedics?

Psychemedics announced a quarterly dividend on Tuesday, October 23rd. Stockholders of record on Friday, November 2nd will be paid a dividend of $0.18 per share on Monday, November 12th. This represents a $0.72 annualized dividend and a dividend yield of 4.83%. The ex-dividend date of this dividend is Thursday, November 1st. View Psychemedics' Dividend History.

How were Psychemedics' earnings last quarter?

Psychemedics Corp. (NASDAQ:PMD) released its quarterly earnings data on Tuesday, October, 23rd. The company reported $0.23 EPS for the quarter. The business had revenue of $11.02 million for the quarter. Psychemedics had a net margin of 14.24% and a return on equity of 26.58%. View Psychemedics' Earnings History.

When is Psychemedics' next earnings date?

Psychemedics is scheduled to release their next quarterly earnings announcement on Wednesday, March 6th 2019. View Earnings Estimates for Psychemedics.

Has Psychemedics been receiving favorable news coverage?

Media headlines about PMD stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research firm scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Psychemedics earned a daily sentiment score of 1.9 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near future.

Who are some of Psychemedics' key competitors?

Who are Psychemedics' key executives?

Psychemedics' management team includes the folowing people:
  • Mr. Raymond C. Kubacki Jr., Chairman, CEO & Pres (Age 73)
  • Mr. Neil Lerner, VP of Fin. & Treasurer (Age 50)
  • Dr. Michael I. Schaffer, VP of Laboratory Operations (Age 73)
  • Dr. Werner A. Baumgartner Ph.D., Founder
  • Ms. Annette Baumgartner, Founder

Who are Psychemedics' major shareholders?

Psychemedics' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (8.49%), Deprince Race & Zollo Inc. (5.23%), Crawford Investment Counsel Inc. (4.63%), Tieton Capital Management LLC (4.52%), Uniplan Investment Counsel Inc. (2.73%) and Blair William & Co. IL (1.94%). Company insiders that own Psychemedics stock include James V Dyke, Michael I Schaffer, Neil Lerner and Raymond C Kubacki Jr. View Institutional Ownership Trends for Psychemedics.

Which institutional investors are selling Psychemedics stock?

PMD stock was sold by a variety of institutional investors in the last quarter, including Tieton Capital Management LLC, Uniplan Investment Counsel Inc., Janney Montgomery Scott LLC, LSV Asset Management and Blair William & Co. IL. Company insiders that have sold Psychemedics company stock in the last year include Michael I Schaffer and Neil Lerner. View Insider Buying and Selling for Psychemedics.

Which institutional investors are buying Psychemedics stock?

PMD stock was acquired by a variety of institutional investors in the last quarter, including Deprince Race & Zollo Inc., Renaissance Technologies LLC, Quantum Capital Management, Crawford Investment Counsel Inc., RBF Capital LLC, Seizert Capital Partners LLC and North Star Investment Management Corp.. View Insider Buying and Selling for Psychemedics.

How do I buy shares of Psychemedics?

Shares of PMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Psychemedics' stock price today?

One share of PMD stock can currently be purchased for approximately $14.91.

How big of a company is Psychemedics?

Psychemedics has a market capitalization of $87.29 million and generates $39.70 million in revenue each year. Psychemedics employs 231 workers across the globe.

What is Psychemedics' official website?

The official website for Psychemedics is http://www.psychemedics.com.

How can I contact Psychemedics?

Psychemedics' mailing address is 289 GREAT ROAD, ACTON MA, 01720. The company can be reached via phone at 978-206-8220.


MarketBeat Community Rating for Psychemedics (NASDAQ PMD)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  106 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  163
MarketBeat's community ratings are surveys of what our community members think about Psychemedics and other stocks. Vote "Outperform" if you believe PMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/18/2018 by MarketBeat.com Staff

Featured Article: How a Put Option Works

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel